Achillion Pharmaceuticals, Inc.

Basic Information

Achillion Pharmaceuticals, Inc.
300 George St, Ste 801
New Haven, CT, 06511 0665

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Antibacterial Agents That Target DNA Replication in Mycobacterium tuberculo

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Mycobacterium tuberculosis (MTB) is probably the most ubiquitous microbial pathogen in the world today infecting one-third of the total population and causing mill ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Capsid assembly inhibitors for the treatment of AIDS

    Amount: $597,665.00

    DESCRIPTION (provided by applicant): Current HIV-1 therapy suffers from inadequate viral load suppression due to poor compliance, resistance, and interactions with other drugs and can lead to spread o ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government